Nearly 20 years after Viagra hit the market, and with 26 drugs approved to treat sexual complaints in men, the U.S. Food and Drug Administration (FDA) has finally approved a drug that addresses sexual dysfunction in women. It is estimated that up to 20% of women in the U.S. suffer from hypoactive sexual desire disorder (HSDD). The fact that women … [Read more...]
Zofran and Atrial Septal Defect
Several studies have found that Zofran use during pregnancy significantly increases the risk of birth defects, including heart defects. In 2014, a study by Swedish researchers, published in Reproductive Toxicology, found that Zofran use in early pregnancy doubled the risk of septal heart defects. Zofran was illegally marketed as a safe treatment … [Read more...]
Zofran Linked to Hypospadias Birth Defect
At least one mother has filed a lawsuit against Zofran (ondansetron) maker GlaxoSmithKline (GSK), alleging that the drug caused her son’s birth defect. In hypospadias, the opening of the urethra is not at the tip of the penis, but somewhere along the shaft or where the penis and scrotum meet. Hypospadias in baby boys has been associated with Zofran … [Read more...]
Experts Advised against Invokana FDA Approval
In March, 2013, the U.S. Food and Drug Administration (FDA) approved Invokana (canagliflozin) for use in treating type 2 diabetes in spite of the fact that five out of 15 experts voted against approving the drug and those who voted in favor of the drug had some serious reservations about its safety. The FDA questioned the safety of Invokana too, … [Read more...]
Symptoms of Invokana Kidney Failure
If you or someone you care about is taking Invokana (canagliflozin) for type 2 diabetes, you need to know how to recognize the signs of kidney failure. Kidney failure is fatal if left untreated. Those who are treated early enough may avoid permanent injury. Invokana was linked to at least 54 cases of renal impairment and kidney failure in its first … [Read more...]
- « Previous Page
- 1
- …
- 23
- 24
- 25
- 26
- 27
- …
- 45
- Next Page »
Recent Comments